Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Hermeking

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Cancer Research|April 2, 2017
<i>miR-34a</i> and <i>miR-34b/c</i> Suppress Intestinal TumorigenesisLongchang Jiang, Heiko Hermeking
Neoplasia (New York, N.Y.)|June 25, 2025
miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancerMatjaz Rokavec, Heiko Hermeking
Seminars in Cancer Biology|May 16, 2006
14-3-3 proteins in cell cycle regulationHeiko Hermeking, Anne Benzinger
Seminars in Cancer Biology|May 16, 2006
Epigenetic silencing of 14-3-3sigma in cancerDmitri Lodygin, Heiko Hermeking
Journal of Molecular Medicine (Berlin, Germany)|May 20, 2014
ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancerStefanie Hahn, Heiko Hermeking
Biochimica Et Biophysica Acta|April 15, 2014
MicroRNAs as regulators and mediators of c-MYC functionRene Jackstadt, Heiko Hermeking
Cellular and Molecular Gastroenterology and Hepatology|March 5, 2019
Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 AxisMatjaz Rokavec, Nassim Bouznad, Heiko Hermeking
International Journal of Biological Sciences|September 14, 2023
Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with <i>p53</i> mutation and elevated c-<i>MYC</i> expressionYuyun Du, Matjaz Rokavec, Heiko Hermeking
Cancer Research|July 5, 2021
<i>14-3-3σ</i> Functions as an Intestinal Tumor SuppressorMarkus Winter, Matjaž Rokavec, Heiko Hermeking
Oncogene|October 19, 2004
Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expressionDimitri Lodygin, Joachim Diebold, Heiko Hermeking
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Cancer Research|April 2, 2017
<i>miR-34a</i> and <i>miR-34b/c</i> Suppress Intestinal TumorigenesisLongchang Jiang, Heiko Hermeking
Neoplasia (New York, N.Y.)|June 25, 2025
miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancerMatjaz Rokavec, Heiko Hermeking
Seminars in Cancer Biology|May 16, 2006
14-3-3 proteins in cell cycle regulationHeiko Hermeking, Anne Benzinger
Seminars in Cancer Biology|May 16, 2006
Epigenetic silencing of 14-3-3sigma in cancerDmitri Lodygin, Heiko Hermeking
Journal of Molecular Medicine (Berlin, Germany)|May 20, 2014
ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancerStefanie Hahn, Heiko Hermeking
Biochimica Et Biophysica Acta|April 15, 2014
MicroRNAs as regulators and mediators of c-MYC functionRene Jackstadt, Heiko Hermeking
Cellular and Molecular Gastroenterology and Hepatology|March 5, 2019
Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 AxisMatjaz Rokavec, Nassim Bouznad, Heiko Hermeking
International Journal of Biological Sciences|September 14, 2023
Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with <i>p53</i> mutation and elevated c-<i>MYC</i> expressionYuyun Du, Matjaz Rokavec, Heiko Hermeking
Cancer Research|July 5, 2021
<i>14-3-3σ</i> Functions as an Intestinal Tumor SuppressorMarkus Winter, Matjaž Rokavec, Heiko Hermeking
Oncogene|October 19, 2004
Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expressionDimitri Lodygin, Joachim Diebold, Heiko Hermeking
Pageof 12